The trajectory of Sildenafil presents a interesting case for stakeholders in the medicinal sector. While initially a phenomenal success, generating vast sums, the patent lapse and the subsequent arrival of generic https://knockoff997749.ezblogz.com/73620158/sildenafil-and-pharma-a-hazardous-investment